Seed IP partners, Chandra E. Eidt and Jeffrey C. Pepe, Ph.D., are moderating a panel at the upcoming BIO IP Counsels Committee (BIO-IPCC) conference, taking place April 8-10 in Denver, Colorado. The panel, sponsored by Seed IP Law Group, is entitled, “Biosimilars: Where are we now and where are we going?,” and is set for Wednesday, April 10 from 8:30-9:45 a.m. This panel will discuss the evolving landscape of US and EP biosimilar approvals and patent considerations. Also to be discussed are biosimilar patent prosecution and litigation strategies, as well as risk assessment and management for developing biosimilars.

Speakers on this panel are:
Michael W. Johnson, Partner, Willkie Farr & Gallagher LLP
Gonzalo Merino, Ph.D., J.D., Vice President, Chief Intellectual Property Counsel, Regeneron Pharmaceuticals, Inc.
Dr. Leonard L. Werner-Jones, Partner, European Patent Attorney, Hoffmann Eitle

Official website and agenda for BIO-IPCC

Read more about Chandra E. Eidt

Read more about Jeffrey C. Pepe, Ph.D.

Supporting you during the COVID-19 pandemic
Seed IP partners co-author article, “When Proxy Services Enable Abuse”
Two law students receive Seed IP Law Group Founders Scholarships 2019-2020
Seed IP Law Group Welcomes Dr. Janaki Purushe as Technical Advisor
More News & Events